Instrument Inactif

Communiqués ehave Inc Other OTC

Actions

CA28238M1068

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

EHAVE : Departure of Directors or Certain Officers - Form 6-K	03/06	PU
EHAVE : Changes in Registrant’s Certifying Accountant - Form 6-K	24/05/23	PU
EHAVE : Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review - Form 6-K	02/05/23	PU
Ehave Provides Progress Update on its HPPD Study with University of Melbourne	02/02/23	AQ
FDA Grants Ehave Consent to Proceed With Its Clinical Study on Intravenous Ketamine Infusion for Major Depressive Disorder	15/12/22	AQ
Ehave Shareholder from CEO Ben Kaplan and Corporate Update	07/12/22	AQ
Ehave, Inc. Announces its KetaDASH Mobile Unit will be Delivered to Miami Beach on June 10, 2022	03/06/22	AQ
Ehave, Inc. Announces Psychedelics Precision Medicine Platform For Clinical Research	01/06/22	AQ
Ehave Announces Mycotopia Therapies Reaches Definitive Agreement on Triangular Merger with Ei.Ventures to Form PSLY.com to List on NASDAQ	23/05/22	AQ
Ehave Inc. (Stock Symbol: EHVVF) Announces MetaHealthU Will Enter The Market With A Focus On HPPD	20/04/22	AQ
Ehave Announces MetaHealthU Will Enter The Market With A Focus On HPPD	19/04/22	AQ
Ehave Continues Expansion Of KetaDASH Mobile Psychedelic Service By Providing Licensed Psychotherapists And Registered Nurses	03/03/22	AQ
Ehave, Inc. Licensing Partner Vastmindz Seen By Millions Of Viewers On Unicorn Hunter	24/02/22	AQ
Ehave, Inc. Launches KetaDASH, Its In-Home Ketamine Therapy In The San Francisco And Sacramento Market	15/02/22	AQ
Ehave, Inc. Expands Its KetaDASH Brand And Begins Producing Revenue With The Purchase Of California Based Rejuv IV	09/02/22	AQ
Ehave Issues Shareholder Letter and Provides Corporate Update	31/01/22	AQ
Ehave Plans Stock Distribution; Mycotopia Therapies Plans To Merge With Ei. Ventures	08/12/21	AQ
Ehave, Inc. To Sponsor Major Psychedelics Conference, Wonderland: Miami	05/11/21	NE
EHAVE : 2021 Psychedelic Investor Guide Released	20/10/21	AQ
Ehave : Hires Contract Research Organization To Conduct Ketamine Clinical Trial In Miami, Florida	12/10/21	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués ehave Inc Other OTC

Actions

CA28238M1068

Communiqués

Filtres